Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Published Dec 20, 2019

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

NOW
PLAYING
The EEE-Mosquito Virus Is Coming - Should People With Cancer Be Worried? How To Protect Yourself
NOW
PLAYING
Hospitals are Seeing a Spike in Late-Stage Cancers as COVID-19 Restrictions Lift - What to Do if You Have Symptoms
NOW
PLAYING
Black Melanoma Patients Experience Significant Treatment Delays, According To Research
NOW
PLAYING
We're Always Hearing About the Health Benefits of 'Superfood' Blueberries - Can They Actually Prevent or Treat Cancer?
NOW
PLAYING
Zero Booze is Best For Cancer Prevention & Five Hours Per Week Of Exercise! New American Cancer Society Prevention Guidelines
NOW
PLAYING
New Research Shows People With Cancer More Likely to Die of COVID-19 - Breaking Down the Data
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.